Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high ‐risk grade 2 glioma: An analysis of the National Cancer Data Base
CONCLUSIONSNo long‐term OS difference was seen in patients with high‐risk grade 2 gliomas treated with CA versus CRT. These findings are hypothesis‐generating, and prospective clinical trials comparing these treatment paradigms are warranted. Cancer 2017. © 2017 American Cancer Society.
Source: Cancer - Category: Cancer & Oncology Authors: Jaymin Jhaveri, Yuan Liu, Mudit Chowdhary, Zachary S. Buchwald, Theresa W. Gillespie, Jeffrey J. Olson, Alfredo D. Voloschin, Bree R. Eaton, Hui ‐Kuo G. Shu, Ian R. Crocker, Walter J. Curran, Kirtesh R. Patel Tags: Original Article Source Type: research
More News: Academia | Astrocytoma | Brain Tumor | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Glioma | Radiation Therapy | Study